November 30, 2011 — In patients with diabetes mellitus (DM) and chronic kidney disease (CKD), hemoglobin A 1c (HbA 1c) targets that fall between 7% and 9% may be associated with decreased risk for ...
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic ...
The cardiovascular benefits observed with intensive blood pressure (BP) control in patients with hypertension and elevated cardiovascular risk from the Systolic Blood Pressure Intervention Trial ...
Sevelamer carbonate 800 mg; tabs. Patients with CKD can develop hyperphosphatemia as a result of retained phosphorus, which may lead to ectopic calcification. Hyperphosphatemia plays a role in the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An FDA advisory panel voted 3-11 against approving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results